Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Immutep Ltd ADR (IMMP)

Immutep Ltd ADR (IMMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 333,561
  • Shares Outstanding, K 85,092
  • Annual Sales, $ 2,960 K
  • Annual Income, $ -22,340 K
  • 60-Month Beta 2.17
  • Price/Sales 110.78
  • Price/Cash Flow N/A
  • Price/Book 6.11
Trade IMMP with:

Options Overview

Details
  • Implied Volatility 77.69%
  • Historical Volatility 67.39%
  • IV Percentile 35%
  • IV Rank 35.43%
  • IV High 144.46% on 06/07/21
  • IV Low 41.05% on 07/20/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 62
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 412
  • Open Int (30-Day) 810

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.07 +27.69%
on 08/19/21
4.46 -12.09%
on 09/07/21
+0.64 (+19.51%)
since 08/17/21
3-Month
3.07 +27.69%
on 08/19/21
4.54 -13.66%
on 06/21/21
-0.77 (-16.42%)
since 06/16/21
52-Week
1.53 +156.21%
on 10/02/20
7.95 -50.69%
on 12/10/20
+2.32 (+145.00%)
since 09/17/20

Most Recent Stories

More News
Thinking about buying stock in Safe-T Group, SOS Ltd, Astrotech, Immutep, or Zomedica?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SFET, SOS, ASTC, IMMP, and ZOM.

SFTTY : 2.0000 (-33.33%)
ZOM : 0.5242 (-2.80%)
IMMP : 3.92 (+1.55%)
SFET : 1.1700 (+1.74%)
ASTC : 1.0600 (+3.92%)
SOS : 2.65 (+2.32%)
Thinking about buying stock in Cellect Biotechnology, Castor Maritime, AMC Entertainment, Immutep, or Hall of Fame Resort & Entertainment?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APOP, CTRM, AMC, IMMP, and HOFV.

CTRM : 2.55 (-1.16%)
HOFV : 3.10 (+8.77%)
IMMP : 3.92 (+1.55%)
APOP : 6.70 (+5.68%)
AMC : 44.20 (-4.00%)
Company News for Sep 21, 2020

Companies in the news are: RHHBY, PIC, IMMP, JAX

RHHBY : 46.0700 (-1.60%)
IMMP : 3.92 (+1.55%)
JAX : 13.94 (unch)
PIC : 19.54 (+27.55%)
WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratulates...

IMMP : 3.92 (+1.55%)
WXXWY : 31.5000 (+5.31%)
WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratulates...

IMMP : 3.92 (+1.55%)
WXXWY : 31.5000 (+5.31%)
Edison Issues ADR Update On Immutep (IMMP)

LONDON, UK / ACCESSWIRE / July 2, 2019 / Immutep's AIPAC Phase IIb study of its antigen-presenting cell activator eftilagimod alpha (efti) plus chemotherapy in breast cancer is fully recruited and expected...

GSK : 38.93 (-0.46%)
IMMP : 3.92 (+1.55%)
MRK : 71.68 (-0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Immutep Limited is a biotechnology company. It engaged in developing novel immunotherapy treatments for cancer and autoimmune disease. The company's product pipeline consists of eftilagimod alpha, IMP731, IMP701 and IMP761 which are in clinical stage. It operates primarily in Europe, Australia and the...

See More

Key Turning Points

3rd Resistance Point 4.31
2nd Resistance Point 4.16
1st Resistance Point 4.04
Last Price 3.92
1st Support Level 3.76
2nd Support Level 3.61
3rd Support Level 3.49

See More

52-Week High 7.95
Fibonacci 61.8% 5.50
Fibonacci 50% 4.74
Fibonacci 38.2% 3.98
Last Price 3.92
52-Week Low 1.53

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar